Ropes & Gray client GlaxoSmithKline is facing a wide-ranging corruption probe from Beijing, but has also faced a probe from Washington under a US law against corruption in other countries.
NEW YORK (TheStreet) -- Shares of GlaxoSmithKline Plc (GSK_) are down 0.71% to $46.45 in pre-market trade after it was reported that a U.S.
“For many short-term traders a tidy profit has been made with some taking their profits in the early hours of Friday,” Campbell said. “But beyond any short-term profits that people may have made in the currency or equity markets throughout this week, the longer term prospects for the U.K. should now be better, especially as all the uncertainty surrounding the referendum is gone.”
You have to keep in mind who's running the company when you talk about "a new low".
Sentiment: Strong Sell
GlaxoSmithKline plc logo Deutsche Bank reaffirmed their hold rating on shares of GlaxoSmithKline plc (LON:GSK) in a research note issued to investors on Wednesday.
The center is being developed as a partnership between Texas A&M University in College Station and pharmaceutical giant GlaxoSmithKline. Once operational, the center will help protect the public against infectious disease and the threat of bioterrorism.
News of the incident broke in early September when security blogger Brian Krebs reported multiple banks found evidence that the retailer may have been penetrated.
These companies may be thousands of miles and many time zones away from Silicon Valley, but, says Geoff Yang, a partner with Redpoint Ventures, they are already "at our doorstep."
GlaxoSmithKline (NYSE:GSK) has long been a top global pharmaceutical company with headquarters in Britain. Gilead Sciences (NASDAQ:GILD) has recently generated so much revenue and profit from a single therapy, Sovaldi for Hepatitis C, or HCV, that ...
A court has fined British drug maker GlaxoSmithKline three billion yuan (#$%$381m) and sentenced its British former manager in China and others to prison for bribing doctors and hospitals to use its products, a state news agency reported.
Beijing (dpa) - A Chinese court on Friday fined London-based GlaxoSmithKline 3 billion yuan (490 million dollars) and sentenced the former head of GSK China to three years in prison for bribery, state media said.
British drug giant GlaxoSmithKline has been fined Rmb300bn (£297m) by Chinese authorities over a bribery scandal that has ensnared the company for more than a year.
HAMILTON - GlaxoSmithKline Vaccines has agreed to pay a $172,900 fine to resolve a Clean Air Act violation at its Hamilton plant, the U.S.
GlaxoSmithKline (GSK) has been fined almost £300m by a court in China in relation to an investigation into bribery. The pharmaceutical firm confirmed the £297m penalty imposed by the Changsha Intermediate People's Court in Hunan Province, saying it ...
The patent cliff has paid a visit to nearly every major pharma in the past few years. As a result, we've seen major changes sweeping across the sector, leading to the development of new breakthrough therapies, consolidations of product pipelines ...
China Fines British Drug Maker GlaxoSmithKline $492 Million, Jails Executives in Bribery Case. BEIJING - Sep 19, 2014, 4:18 AM ET.
GlaxoSmithKline has been found guilty of bribery by a Chinese court and has agreed to pay a fine of £3bn (£297m) to the government in Beijing.
Today's "Emerging Growth" article is nothing more than paid for promotional advertising.
Gotta hand it to the Isaac team, it's such a great way to spend the company's funds..............
Sentiment: Strong Sell
Even after five years of steady economic growth, Federal Reserve Chair Janet Yellen is likely to raise interest rates only gradually between 2015 and 2017 as inflation remains muted, according to a Bloomberg survey of economists.